Note: Ingredients listed on restricted chemical lists
EC/CAS
9002-84-0
Name of the chemical
Polytetrafluoroethylene
Concentration
N/A
EC/CAS
50-00-0
Name of the chemical
Formaldehyde
Concentration
N/A
General Information
Revision date
2007-04-20
Product name
"DELRIN" ACETAL RESIN/PTFE BLENDS ON SYNONYM LIST DEL012
Product name
"DELRIN" ACETAL RESIN/PTFE BLENDS ON SYNONYM LIST DEL012
Identification on the label/Trade name
"DELRIN" 100AF NC010
Icons in SDS
Company Information
company name
DuPont Engineering Polymers
Section 2
SECTION 2: Hazards identification
Potential health effects
ADDITIONAL HEALTH EFFECTS Read the specific datasheet for product to be used before using this resin, as well as the Delrin Molding Guide. ACETAL POLYMER There are no known effects from exposure to the Delrin polymer itself. If overheated, the polymer releases formaldehyde which may cause skin, eye, and respiratory irritation and allergic reactions. Significant skin permeation and systemic toxicity after contact appears unlikely. There are inconclusive or unverified reports of human sensitization. POLYTETRAFLUOROETHYLENE (PTFE) Inhalation of PTFE dust may cause generalized irritation of the nose, throat and lungs with cough, difficulty breathing or shortness of breath. Heating PTFE above 300 degrees C may liberate a fine particulate fume. Inhalation may produce polymer fume fever, a temporary flu-like condition with fever, chills, nausea, shortness of breath, chest tightness, muscle or joint ache, and sometimes cough and elevated white blood cell count. The symptoms are often delayed 4 to 24 hours after exposure. These signs are generally temporary, lasting 24-48 hours and resolve without further complications. However, some individuals with repeated episodes of polymer fume fever have reported persistent pulmonary effects. Protection against polymer fume fever should also provide protection against any potential chronic effects. Continued) Exposure to decomposition products from PTFE heated above 400 degrees C may cause pulmonary inflammation, hemorrhage or edema. These more serious consequences of exposure may occur from extreme thermal decomposition of PTFE which can liberate fume particles, and toxic gases (carbonyl fluoride, hydrogen fluoride, and other fluorinated gases) especially under conditions of poor ventilation and/or confined spaces. These decomposition products may initially produce chest tightness or pain, chills, fever, nausea, with shortness of breath, cough, wheezing and progression into pulmonary edema. Edema may be delayed in onset and requires medical treatment. In severe cases, if medical intervention is delayed, pulmonary edema may become life threatening. Recovery is generally complete within a few days; in some rare cases, persistent lung function abnormalities have been reported. Compared to nonsmokers, polymer fume fever symptoms appear to be more prevalent and serious in smokers. Smokers must avoid contamination of tobacco with residual polymer from their hands or from fumes, and should wash their hands before smoking. Significant skin permeation, and systemic toxicity, after contact with the dust appears unlikely. There are no reports of human sensitization from contact with the dust. If PTFE dusts contact the eye, mechanical irritation with tearing, pain or blurred vision may result. Individuals with pre-existing diseases of the lungs or cardiovascular system may have increased susceptibility to the reduction in blood oxygen that may develop after excessive exposures to thermal decomposition products. Carcinogenicity Information The following components are listed by IARC NTP